PsyPost on MSN
Scientists just uncovered a major limitation in how AI models understand truth and belief
A new evaluation of artificial intelligence systems suggests that while modern language models are becoming more capable at ...
Hosted on MSN
11 Most Useful ls Command Flags
If you use the terminal often, you probably know the ls command. It lists what's in a folder, but if you add some flags it can do a lot more. You can view extra details, locate files faster, and get ...
Recursion Pharmaceuticals ( RXRX +1.91%) was in the headlines on Monday, and for the right reason. One of the biotech company's investigational drugs did well in a clinical trial, and investors ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
The West woke up Wednesday to news of a Lexus LS comeback that was announced at the 2025 Japan Mobility Show. However, it’s no longer the flagship sedan we all know and love. Instead, Lexus assigned ...
View post: Walmart Is Selling an 'Incredibly Powerful' $160 Pressure Washer for Just $79, and It's an 'Awesome Cleaning Tool' The Lexus LS was the sedan that showed the world Japan could truly compete ...
Lexus has brought a slew of intriguing concept cars to the Japan Mobility Show in Tokyo, and among them, the LS Concept is the most fascinating. It is a weird six-wheeled ultra-luxury van that was ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
It’s been more than three decades since Toyota introduced its luxury division with the original Lexus LS 400. Launched in 1989 as a 1990MY, the full-size sedan proved you didn’t need a German passport ...
Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...
As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results